Advertisement
The loss attributable to common shareholders for the third quarter of 2007was ($212,282) or ($0.004 per share), compared to income of $357,455 or $0.005per share, in same period of 2006. The income in the third quarter of 2006 wasrelated to the settlement of a lawsuit in the period. Included in the loss inthe third quarter of 2007, is a loss from discontinued operations of($57,209), resulting from losses at its Family Medical Clinic operations.Effective July 31, 2007, the Company sold one of its two remaining FamilyMedical Clinics.
Advertisement
The Company's financial statement information for the three and ninemonths ended September 30, 2007 is summarized below:
MedEmerg specializes in the coordination and delivery of health careservices in Canada. These services include community-based infusion centers,an integrated chronic pain management program, healthcare consulting, andhealth human resource management, including physician and nurse staffing.
All statements included in this press release that are not statements ofhistorical fact are forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995. The words "plan", "expect","believe", "intend", "anticipate", "forecast", "target", "estimate" andsimilar expressions identify forward-looking statements. Forward-lookingstatements are based on assumptions made by and information currentlyavailable to the Company. Investors are cautioned that these forward-lookingstatements are neither promises nor guarantees, and are subject to risks anduncertainties that may cause future results to differ materially from thoseexpected. These risks and uncertainties are outlined in the Company's AnnualReport on Form 10-K for 2006, its Quarterly Reports on Form 10-Q, and suchother documents as are filed with the Securities and Exchange Commission fromtime to time. The Company does not undertake to review or update theseforward-looking statements. The Company qualifies all of the informationcontained in this press release, and particularly its forward-lookingstatements, by these cautionary statements.(US$000's except share Three Months Ended Nine Months Ended information) Sept 30 Sept 30 ----------------------- ----------------------- 2007 2006 2007 2006 Revenue 5,757 4,130 16,181 13,171 EBITDA (33) (132) (225) 184 Loss from continuing operations (155) (188) (514) (62) Income (loss) from discontinued operations (57) 545 (179) 1,181 Net income (loss) attributable to common shareholders (212) 357 (693) 1,119 Net income (loss) per common share (basis and diluted) Continuing operations (0.003) (0.
